Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Neurogenic Dysphonia/Dysphagia Registry

ClinicalTrials.gov ID: NCT02493491

Public ClinicalTrials.gov record NCT02493491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Neurogenic Dysphonia/Dysphagia Registry is designed to be purely observational (i.e. non-interventional, exploratory). Patient data collected from the registry is expected to be consistent with any information which can be obtained during usual care of patients with dysphonia/dysphagia treated with vocal fold augmentation.

Study identification

NCT ID
NCT02493491
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Merz North America, Inc.
Industry
Enrollment
146 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2015 (Type not available)
Primary completion
Aug 2016 (Actual)
Completion
Sep 2016 (Actual)
Last update posted
Sep 9, 2016

2015 – 2016

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Merz Clinical Site La Jolla California 92037 —
Merz Clinical Site Sacramento California 95817 —
Merz Clinical Site Augusta Georgia 30912 —
Merz Clinical Site Boston Massachusetts 02115 —
Merz Clinical Site Burlington Massachusetts 01805 —
Merz Clinical Site 0010334 New York New York 10016 —
Merz Clinical Site 0010068 New York New York 10019 —
Merz Clinical Site 0010333 Sleepy Hollow New York 10591 —
Merz Clinical Site Durham North Carolina 27710 —
Merz Clinical Site 0010332 Pittsburgh Pennsylvania 15219 —
Merz Clinical Site Houston Texas 77030 —
Merz Clinical Site Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02493491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2016 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02493491 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →